cgh-asgcr (Speakers)


[Note: Speakers are listed in alphabetical order. See the Symposium Agenda for their speaking roles. Information is subject to change.]


  • UCLA HCM Headshots 2_4_2020-108.jpg
    Rifa I Akanda, M.P.H.
    Graduate Student Researcher, University of California, Los Angeles

    Los Angeles, United States

    Rifa Akanda is a Master's of Public Health candidate at UCLA studying Health Policy and Management. Rifa is currently working at Cedars Sinai Cancer and is organizing the Cancer Center Community Impact Forum along with developing an HPV vaccination campaign to increase HPV vaccine uptake in the Los Angeles LGBT+ community. Rifa has researched the impact of social support on adherence to breast cancer medication, the impact of social support on opioid abuse, as well as the cervical cancer policy landscape in sub Saharan Africa and it's relation to various economic and social indicators across the region. Rifa greatly enjoys learning about cancer and how to decrease the burden of cancer in various communities. She hopes to continue her work in cancer control and research in her future endeavors after graduation.

  • Karla Alfaro.jpg
    Karla Alfaro, MD MPH
    Medical Director, Basic Health International

    San Salvador, El Salvador

    Karla Alfaro, MD MPH is Medical Director at Basic Health International, a non-profit dedicated to the elimination of cervical cancer through research, advocacy, and outreach in low-income settings. Dr. Alfaro received her medical degree from Universidad Dr. Matias Delgado in El Salvador and obtained her Master’s Degree from Universidad Evángelica de El Salvador.
    Over the last 10 years, Dr. Alfaro has worked tirelessly to bring cervical cancer screening, diagnosis, and treatment to women in low and middle-income countries and has conducted pioneering research in El Salvador, Haiti, Colombia, and China. She is part of a team that pioneered the implementation of novel strategies to combine large-scale screening with immediate treatment in El Salvador. The paradigm pioneered by Dr. Alfaro and her colleagues was adopted by the government of El Salvador and is currently a national program. As part of her global public health work, Dr. Alfaro has been involved in the creation of technical and training manuals on HPV testing implementation for the World Health Organization, the Pan American Health Organization, and the Center for Disease Control. More recently, she has brought her expertise and fieldwork experience to the implementation of COVID-19 testing in El Salvador. Dr. Alfaro is a dedicated physician, researcher, and public health advocate, and her work has touched the lives of countless women in El Salvador and around the world.

  • Allen_Carl_2k19-0615-AK4_2927 5x7.jpg
    Carl E. Allen, M.D., Ph.D.
    Professor, Baylor College of Medicine

    Houston, United States

    My overall professional goal is to improve outcomes for children with cancer and blood disorders by addressing areas of greatest unmet need through innovative research, collaboration and mentorship. I am currently Associate Professor of Pediatrics at Baylor College of Medicine, Co-Director of the Lymphoma and Histiocytosis Programs. My research group focuses on clinical and translational research efforts to develop and test improved therapeutic strategies for children with histiocytic disorders, lymphoproliferative disorders and lymphomas. As Director of Research for Global HOPE, I am also working with colleagues to develop and deploy capacity-building initiatives for care of children with cancer and blood disorders in Sub-Saharan Africa.

  • ChitePic.jpg
    Fredrick C Asirwa, M.D.
    Executive Director/CEO/Medical Oncologist & Hematologist, International Cancer Institute

    Eldoret, Kenya

    I am the CEO/Executive Director of International Cancer Institute (ICI) that has cancer care and control activities and programs with various strategic partners in Sub-Saharan Africa. I am also the Program Director/PI of Blueprint for Innovative Access Program, which brings together various implementing partners working on a cancer project in one geographical region across the continuum of the patient's journey. In addition, to increase personalized medicine and optimize standards of care (SOC) in Africa, I am the Program Director for the Shining Tower Program (STP), a partnership between ICI and Roche, working in over 15 counties in Kenya to improve education, research and training in cancer across all cadres of HCP, enhance early detection, promote HPV screening in our cervical programs, provide SOC diagnostics and therapeutics and enhance cancer research. Through our Africa-wide virtual preceptorships training, ICI has created more than 50 online preceptorship modules (Breast Cancer, Multiple Myeloma, Prostate Cancer, Lymphoma, Cervical Cancer, GTN etc) with over 2000 HCP trained across 14 countries in Africa. ( From 2011 to 2019, I was the Director of AMPATH, KENYA. I successfully conceptualized, spearheaded and developed infrastructure for telemedicine, Fellowship programs, Nursing Onc & Middle-level trainings in Eldoret, created a hematology and oncology outreach program to various sites in Western Kenya and participated in the development of the Kenya National Cancer Control policies and guidelines by MOH amongst many research projects and programs. ICI is leading clinical trials, education & training, clinical care and outreach work in Kenya and SSA.

  • Atun High Res 2.jpg
    Professor of Global Health Systems, Harvard University

    Boston, United States

    Dr. Atun is Professor of Global Health Systems at Harvard University and Faculty Chair of the Harvard Ministerial Leadership Program. In 2008-12 he was a member of the Executive Management Team of the Global Fund as Director of Strategy, Performance and Evaluation. In 2006-2013 he was a Professor of International Health Management at Imperial College London, and led the Centre for Health Management. He is a visiting professor at University of Kyoto, Japan. Professor Atun’s research focuses on health systems and innovation. He has published over 380 articles in leading journals such as NEJM, Lancet, JAMA, Academy of Management Journal, and Lancet Oncology. Prof Atun has advised many governments on health policy, and health system reform, and has consulted for the World Bank, WHO. In 2019-20 he was a senior advisor to the G20 Presidency. Professor Atun was a member of the U.S. National Academy of Medicine Committee on Health Systems, the Advisory Boards of WHO Research Centre for Health Development in Japan, Norwegian Research Council’s Programme for Global Health Research, and the UK Medical Research Council’s Global Health Group. He is a member of the Longitude Prize Committee.

    Professor Atun studied medicine at University of London as a Commonwealth Scholar and completed his postgraduate training in family medicine and public health. He obtained a Masters in Business Administration at University of London and Imperial College London. He is a Fellow of the Royal College of Physicians, the Faculty of Public Health, and the Royal College of General Practitioners.

  • Headshot cropped.png
    Antonio Bandala-Jacques, M.D.
    Physician, Instituto Nacional de Salud Pública

    Mexico City, Mexico

    Antonio Bandala-Jacques is a physician who works as a gynecological cancer researcher in Mexico's National Cancer Institute, where he specializes in study design and biostatistical analysis; and as advisor of epidemiology and research methods for Mexico's National Institute of Genomic Medicine. He is currently an MPH student at the National Institute of Public Health in Mexico City, where his focus is assessing outcomes of women with breast cancer who were treated by Mexico's former Seguro Popular (Popular Insurance).

  • NIH-NCI-Headshots-840 small.jpg
    Emma J. Brofsky, M.S.P.H.
    Scientific Program Analyst, National Cancer Institute

    Rockville, United States

    Emma Brofsky is a Scientific Program Analyst in the Division of Cancer Prevention at the National Cancer Institute. She serves as a Project Manager for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet) and supports other projects within the Breast and Gynecological Cancer Research Group and the division. Emma received a B.S. in Biological Sciences from Cornell University and a Master of Science in Public Health in Global Disease Epidemiology and Control from the Johns Hopkins Bloomberg School of Public Health. She has experience working with local, state, and federal public health agencies as well as in international field settings on projects related to emerging infectious disease response, health program implementation, and maternal and child health.

  • PHOTO-Lydia.jpg
    Lydia Businge, MPH
    Cancer Registry Officer, Rwanda Biomedical Center

    Kigali, Rwanda

    Ms. Lydia Businge is a health professional physiotherapist with a Master's degree in Public Health (MPH) from Jomo Kenyatta University of Agriculture and Technology, Kenya. Lydia is currently working at the Rwanda Biomedical Center (RBC), Non-Communicable Diseases/Cancer Unit, as Rwanda Cancer Registry officer under the collaboration between RBC and P20 grant implemented by the Einstein-Rwanda Research and Capacity Building Program (ER-RCBP) at Rwanda Military Hospital. Prior to joining the RBC, Lydia worked as the Cancer Registry Coordinator for 7 years in the former Cancer Registry at Women's access on Care and Treatment (WE-ACT), Regional Alliance for Sustainable Development (RASD-Rwanda) and Rwanda Military Hospital (RMH) as part of the activities of the ER-RCBP. In addition, she has fully participated in the establishment of a National Cancer Registry (NCR) in July 2018 by the Ministry of Health and the RBC to collect national cancer data. She has been involved in a variety of health systems research areas within the IeDEA and U54 NIH grants, that screened cervical cancer and HPV among women living with HIV and Men who Have Sex with men in Rwanda within the ER-RCBP. She participated in the ICASA-2019 held in Kigali, AORTIC, 2019 held in Maputo and U54, 2018 and 2019 consortia conferences on HIV/AIDS-related malignancies in Lilongwe and Dare Salam, where she led and presented the two accepted poster and one oral abstracts, namely: AIDS-defining malignancies (ADMs) from Rwanda cancer registry and Predictors of cervical cancer screening uptake among women living with HIV (WLHIV) in Rwanda respectively.

  • Cyp headshot feb 21.jpg
    Shyirambere Cyprien, M.D.
    Director - Oncology Program, Partners In Health

    Kigali, Rwanda

    As the Director of Oncology Program at Partners In Health (PIH) in Rwanda, Shyirambere Cyprien leads the implementation of cancer care delivery at PIH supported sites In Rwanda. This includes supporting the daily operations of the Butaro Cancer Center of Excellence (BCCOE), the first national referral cancer center in Rwanda, and accompanying Rwanda’s Ministry of Health in designing, implementing and scaling up evidence-based and cost-effective strategies to advance cancer prevention and care in Rwanda.
    He graduated from University of Rwanda with a master’s of Medicine in Pediatrics and child health and received pediatric oncology trainings at Dana Farber Cancer Institute and Boston Children’s hospital. Before joining PIH/IMB in 2014 he was a faculty and head of postgraduate training program in the department of pediatrics at University of Rwanda and a lecturer at Catholic University of Rwanda, faculty of public health.
    As a researcher he is interested in the use of implementation science as a framework for iterative evaluations of our cancer care model, to understand programmatic efficacy, where gaps exist and where improvements can be made. This not only informs changes in clinical practices or policies, it will also offer lessons to others seeking to start cancer centers in low-income settings.

  • headshot.jpg
    Linsey Eldridge, MPH
    Fellow, National Cancer Institute Center for Global Health

    Rockville, United States

    Linsey Eldridge is currently a Cancer Research Training Award Fellow at the National Cancer Institute Center for Global Health where she supports evaluation of global cancer programs. She received her Master of Public Health with a focus in Epidemiology from Tulane University in 2019. She earned her undergraduate degrees in English and Africana Studies from the University of Pittsburgh in 2015. She's passionate about improving health disparities domestically and globally.

  • Gopal, Satish_cropped_2020.jpg
    Satish Gopal, M.D., M.P.H.
    Director, U.S. National Cancer Insistute, Center for Global Health

    Rockville, United States

    Satish Gopal, MD, MPH was appointed Director, Center for Global Health, at the National Cancer Institute (NCI) in February 2020. He oversees the development of initiatives and collaborations with other NCI divisions, NCI-Designated Cancer Centers, and countries to support cancer research and cancer research networks, promote cancer control planning, and build capacity in low- and middle-income countries. Previously, Dr. Gopal was the Cancer Program Director for the University of North Carolina (UNC) Project-Malawi.

    Dr. Gopal completed his Master of Public Health in 2000 at UNC-Chapel Hill and earned his medical degree from the Duke University School of Medicine in 2001. He then completed training in internal medicine and pediatrics at the University of Michigan, lived and worked in Tanzania from 2007-2009, then returned to the U.S. to pursue medical oncology and infectious disease training at UNC-Chapel Hill. He lived with his family in Malawi from 2012-2019, when he was the only certified medical oncologist in a country of ~18 million people. He returned frequently to UNC-Chapel Hill to provide clinical service in the North Carolina Cancer Hospital.

    As an extramural investigator, his NIH-funded research focused on epidemiologic, clinical, and translational studies of lymphoma and HIV-associated malignancies in sub-Saharan Africa, and he oversaw a multidisciplinary cancer research portfolio. He has co-authored 90+ publications, successfully mentored many cancer junior investigators, and spoken widely about global oncology. He had oversight responsibility for African activities of the NCI AIDS Malignancy Consortium (AMC).

  • CROPPED-GRALOW  photo.jpg
    Julie R Gralow, MD
    Chief Medical Officer, American Society of Clinical Oncology

    Alexandria, United States

    Dr. Julie Gralow is the Chief Medical Officer for the American Society of Clinical Oncology effective February, 2021. She is a breast medical oncologist who served >25 years on faculty as Professor of Medical Oncology and Adjunct Professor of Global Health at the University of Washington, Fred Hutchinson Cancer Research Center, and Seattle Cancer Care Alliance. She has served as Executive Officer for Breast and Lung Cancer and Vice Chair of the Breast Cancer Committee for the SWOG Cancer Research Network. She chaired the recent ASCO Academic Global Oncology Task Force, co-chairs the ASCO Resource Stratified Guideline Advisory Group, and received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.

  • 036.jpg
    Franklin W. Huang, M.D., Ph.D.
    Assistant Professor (UCSF), Co-founder (Global Oncology), University of California San Francisco / Global Oncology

    San Francisco, United States

    Dr. Franklin Huang is a physician-scientist and an Assistant Professor of Medicine at the Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco. He is an attending physician at the San Francisco Veterans Affairs Medical Center. He directs a cancer research laboratory at UCSF focused on cancer genomics and understanding the molecular determinants of cancer disparities. His work is aimed at understanding the biological underpinnings of prostate cancer in men of African ancestry. He is the co-founder, with Dr. Ami Bhatt, of Global Oncology, a volunteer-based non-profit organization focused on improving cancer care for underserved patients globally. Since 2017, Global Oncology has helped establish cancer care services and a cancer patient navigation program in Belize through a partnership with Karl Heusner Memorial Hospital in Belize City.

  • Bio Photo CUGH.jpg
    Sharon K. Kapambwe, M.D
    Assistant Director-Cancer Control, Ministry of Health Zambia

    Lusaka, Zambia

    Dr. Sharon Kapambwe is the current Assistant Director Cancer Control at the Ministry of Health in Zambia. Prior to joining the Ministry of Health Dr. Kapambwe worked as Director, cervical cancer prevention program at Centre for Infectious Disease Control (CIDRZ) .
    She is a global public health leader, clinician and researcher notable for leading the development and implementation of the national population-based cervical cancer screening and prevention program in Zambia. Extensive experience with policy formulation, strategic planning and forming and managing effective cross-sector partnerships. Highly reputable technical advisor to senior-level government officials and international organizations. Expert in resource mobilization to support women’s health and non-communicable disease (NCD) programs.

  • Li_Sharon.jpg
    Sharon Li, M.D.
    Hematology/Oncology Fellow, Rutgers Cancer Institute of New Jersey

    New Brunswick, United States

    Sharon Li is a hematology/oncology fellow at the Rutgers Cancer Institute of New Jersey. She recieved her medical degree and internal medicine training at Thomas Jefferson University in Philadelphia, PA. She has broad interests in global oncology, including improving socioeconomic and cultural barriers to cancer care and teaching and training medical personnel -- both in the US and in LMICs. She has been a part of the Botswana-Rutgers Partnership for Health since 2019.

  • IMG_9417.JPG
    Cesaltina Ferreira Lorenzoni , M.D., Ph.D.
    Head, Cancer Control Program, Ministry of Health

    Maputo, Mozambique

    Cesaltina is a professor in the pathology department at the Faculty of Medicine of the Eduardo Mondlane University, the head of the National Cancer Control Program at Mozambique's Ministry of Health, and theScientific and Teaching Director at Maputo Central Hospital. She holds a Master's Degree in Public Health in Cancer Epidemiology through the Faculty of Medicine, Eduardo Mondlane University (MPH), a Master in Policies, Health Program Planning (MSc), and a PhD in International Health, in Translational Epidemiology of Cancer from the University of Barcelona, Spain. She has about 50 articles published in peer reviewed journals, chapters published in two books by the African Cancer Network, IARC, WHO and International Union for Cancer Control (UICC). Cesaltina leads research projects with international institutions, inlcuding as a member of the Education, Training and Research Committee of the largest African Cancer Organization (AORTIC), representing the PALOP (African Portuguese Speaking Languages).

  • 20191026_093103 (2).jpg
    George E Mocha, M.D.
    Urologist, Rabininsia Memorial Hospital

    Dar Es Salaam, Tanzania

    George Mocha is a junior urologist working at Rabininsia Memorial Hospital since his graduation. He graduated from CUHAS - BUGANDO (Catholic University of Health and Allied Sciences ) Mwanza, Tanzania class of 2016 - 2019 MMED- UROLOGY. He did his undergraduate studies at MUHAS (Muhimbili University of Health and Allied Sciences) Dar Es Salaam Tanzania. He is interested in Uro-oncology, endourology and stone management.

  • eMsoka.jpg
    Elizabeth F. Msoka-Bright, PhD Student
    Research Fellow, PhD Student, Kilimanjaro Clinical Research Institute/ Kilimanjaro Christian Medical University College(KCMUCo)

    MOSHI, Tanzania

    Elizabeth Francis Msoka is a registered Postgraduate Nurse-Midwife at Kilimanjaro Christian Medical Centre (KCMC) with 8 years of nursing and midwifery experience in Obstetrics and Gynaecology and more than 15 years’ experience in research.
    She received a bachelor’s degree in Nursing from the Kilimanjaro Christian Medical University College (KCMUCo). Moshi, Tanzania. She also holds a Master’s degree in Advanced Nursing Science from Nottingham University, United Kingdom. She successful completed Pre-PhD in nursing training at Polytechnic University in Hong Kong. Since 2002, she has been involved in the research. She completed the following certificates to expand her research skills: Research methodology from the African Midwives Research Network (AMReN) Zambia, University Teaching Hospital, Health System and Policy research (Western Cape Summer School, SA), Reciprocal Clinical Trial Monitor under East African Consortium for Clinical Research-2 (EACCR2), qualitative data investigation and analysis at Uganda Virus Research Institute (UVRI), Discordant Couple & HIV counselling from Ministry of Health, Tanzania, Practical steps for the archiving of qualitative research data, Cork University. She had been involved in various international studies spanning topics of Anti-microbial resistance, the burden of arthritis, access to care, TB-HIV treatment adherence, female genital cutting and intersection of culture and health. Since 2018, she has been involved in breast cancer research in Moshi. She is currently accepted to the PhD program at (KCMUCo) where her thesis is on " A Qualitative Study of the Factors Contributing to the Late Diagnosis of Breast Cancer in Tanzania: Perceptions of Health Care Providers, Patients, and Traditional Healers".

  • Headshot Mungo copy.png
    Chemtai Mungo, MD, MPH
    Fellow , University of California, San Francisco

    San Francisco , United States

    Dr. Chemtai Mungo was born and raised in Kenya and is an Obstetrician/Gynecologist and Global health fellow at the University of California, San Francisco (UCSF). She received a bachelor’s degree with Honors from the University of California in Berkeley and completed medical training at UCSF. She also holds a Masters’s degree in Public Health from the Johns Hopkins School of Public Health. As a medical student, she was awarded a Doris Duke International Clinical Research Fellowship and spent a year in Kisumu, Kenya working on cervical cancer prevention among HIV-infected women.

    Dr. Mungo is passionate about using clinical research, advocacy, and public health to advance women's health in Sub-Saharan Africa. As a fellow at the University of California San Francisco, she is the Principal Investigator of several studies at PEPFAR funded HIV clinics in Kisumu, Kenya investigating evidence-based cervical cancer prevention initiatives among HIV-infected women, including the use of HPV self-sampling, validation of alternative ablative treatment methods for precancer, and the use of automated algorithms for cervical cancer screening among HIV-positive women. Her work is supported by the National Institute of Health and the UCSF Global Cancer grant.

  • Annotation 2021-02-01 144115.png
    Miriam Mutebi, M.D., MMed Surg, MSc
    Breast Surgical Oncologist, Assistant Professor, Department of Surgery, Aga Khan University Hospital

    Nairobi, Kenya

    Dr. Miriam Mutebi is a Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at Aga Khan University Hospital in Nairobi, Kenya. She is also the Vice-President of East Africa of the African Organization for Research and Training in Cancer (AORTIC), Chairperson for the Kenya Society of Hematology and Oncology (KESHO) and on the Board of Directors of the Union for International Cancer Control(UICC). She is the co-founder of the Pan African Women’s Association of Surgeons and is part of the Kenya Association of Women Surgeons.
    She did her general surgery residency at AKU. She subsequently did a two-year fellowship in Breast Surgical Oncology, which included a year in plastics and reconstruction at the University of Cape Town, Groote Schuur Hospital in South Africa followed by a Mammadi Soudavar International Surgical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center. She continued at Memorial Sloan Kettering for 2 years as a Graduate Surgical Oncology Research Fellow and also completed her Master’s degree in Clinical Epidemiology and Health Systems Research at the Weill Cornell University with a focus towards understanding the barriers to the diagnosis and treatment for women with cancers in Africa, thus designing interventions to mitigate these barriers.
    She is an avid supporter of education and support for women, especially in surgery, and she aims to provide mentorship for women in surgery and to improve women’s health and surgical care in Africa. She is currently pursuing a pilot's licence to extend breast care services to marginalised areas.

  • LNewman_head shot_0.png
    Lisa A. Newman, M.D. MPH FACS FASCO
    Chief, Breast Surgical Oncology Programs, Weill Cornell Medicine - New York Presbyterian Hospital Network

    New York, United States

    Dr. Newman is a surgical oncologist with a practice dedicated to breast cancer management and oversees the breast program for the Weill Cornell Medicine - New York Presbyterian Hospital Network. She is also the Founding Medical Director for the International Center for the Study of Breast Cancer Subtypes, currently headquartered at Weill Cornell Medicine, as well as an adjunct professor at M.D. Anderson Cancer Center.
    Dr. Newman holds a Masters Degree in Public Health from Harvard University, and she also obtained her undergraduate education at Harvard. She attended medical school and completed her general surgery residency training at the State University of New York Downstate Medical Center in Brooklyn, and pursued fellowship training in surgical oncology at the M.D. Anderson Cancer Center.
    Dr. Newman's primary research has focused on race/ethnicity-related variation in breast cancer risk and outcome, the evaluation and management of high-risk patients; broadened applications for neoadjuvant chemotherapy, and special surgical techniques such as the skin-sparing mastectomy and lymphatic mapping/sentinel lymph node biopsy. She also oversees an international breast cancer research and training program focusing on the study of triple negative breast cancer in women with African ancestry. This program involves a network of physicians and facilities in Ghana, Ethiopia, Nigeria, Uganda, Mexico, and the Caribbean.
    Dr. Newman's work has been acknowledged with many awards and she has been appointed to multiple national and reginal leadership positions, including most recently as 2nd Vice President-Elect for the American College of Surgeons.

  • VPS headshot.jpg
    Valerie A Paz-Soldan, Ph.D., MPH
    Associate Professor, Tulane School of Public Health and Tropical Medicine

    Lima, Peru

    I am a Peruvian-American social scientist working for Tulane University and permanently based in Peru where I direct the Tulane Health Office for Latin America. I currently lead two implementation science research projects to assess, prepare, implement, and evaluate strategies for: 1) improving cervical cancer screening programs in Peru, and 2) improving vector borne/zoonotic disease prevention and control, especially focused on dengue, Chagas disease, and canine rabies. Participatory Action Research and community engagement have been at the heart of our Proyecto Precancer project, where our team facilitated an audit and feedback process to surface problems and bottlenecks in the current cervical cancer screening program in a health network in the Peruvian rainforest that was shared with key stakeholders to make decisions about the best cervical cancer screening program for the region. We then facilitated the development and implementation of a contextually feasible and acceptable HPV screen and treat program that has surpassed our goals. In the past two decades, I have worked with multidisciplinary teams, applying both qualitative and quantitative methods, to examine adoption of health prevention practices, at both the individual and community level.

  • DHP in Liberia 2.jpg
    David H. Peters, M.D., M.P.H., Dr.P.H.
    Professor & Chair, Johns Hopkins University School of Public Health

    Baltimore, United States

    David Peters has played a pivotal role in building the field of health systems research in low- and middle-income countries (LMICs) and advancing implementation research (IR) to problems of health equity. He has played a leading role in conceptualizing IR and complex adaptive systems in public health, influencing methodological and educational approaches. He has directed a wide range of implementation and policy research programs, including the Future Health Systems Research Consortium. His research and practice have included pioneering sector-wide approaches for metrics-driven national health programs that have been widely used across Africa and South Asia. He created the first national Balanced Scorecard to manage primary healthcare, which was used in Afghanistan to test health financing and contracting interventions, leading to new improved services and policies, including the abolishment of user fees. In India, his leadership on the analysis of health systems and the poor contributed to new pro-poor national health programs and financing schemes. He has led numerous multi-disciplinary research and capacity-building collaborations with a focus on using data to strengthen health systems. In Liberia he worked with the Ministry of Health to change the Ebola response to an integrated and community-based strategy based on the analysis of outbreak data, leading to a quicker end to the epidemic. He has fostered multi-agency approaches to tackle critical health problems, and made important contributions to numerous global health boards and advisory bodies.

  • C S Pramesh_ 006.jpg
    C. S. Pramesh, M.S, F.R.C.S.
    Director, Tata Memorial Hospital, Tata Memorial Centre

    Mumbai, India

    Dr C S Pramesh is the Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Mumbai. He serves on the Board of Directors of the Union for International Cancer Control (UICC). He is the convener for the National Cancer Grid, a large network of 234 cancer centres, research institutes and patient groups in India ( The mandate of the National Cancer Grid is to provide uniform standards of cancer care across the country. Pramesh is highly committed to efforts towards reducing inequities in cancer care and making cancer treatment accessible to all geographic regions and strata of society. He is a visiting professor at the Division of Cancer Studies, King’s College London and the Institute of Cancer Policy, King’s Health Partners, London.

    His clinical interests include the management of esophageal and lung cancers and minimally invasive surgery. He is the Principal Investigator in several investigator-initiated research studies including randomized trials on cancer screening, surgical techniques, neoadjuvant and adjuvant treatment of thoracic cancers. His broader research interests include cancer policy, health equity, value-based care and health services research. He has more than 200 peer-reviewed journal articles, abstracts and book chapters on various topics including thoracic oncology, clinical research methods, translational research, health equity, and cancer policy.

  • Rositch, Anne_HART0657.jpg
    Anne F. Rositch, PhD, MSPH
    Associate Professor, Johns Hopkins Bloomberg School of Public Health

    Baltimore, United States

    Anne F. Rositch, PhD, MSPH, is an applied epidemiologist, concentrating on cancer prevention and control in women and global cancer disparities, with a background in basic science and experience conducting international field-based research. She has funded research in Baltimore, Peru, and across sub-Saharan Africa, including Kenya, Tanzania, and South Africa. Through her research and leadership activities, Dr. Rositch is committed to finding practical ways to translate existing and new technologies for cancer prevention and control to populations with the highest burden of disease, globally and locally.

    Dr. Rositch is currently an Associate Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, with a joint appointment in the Program in Oncology at the Johns Hopkins School of Medicine and the Sidney Kimmel Comprehensive Cancer Center. She received a Master’s and PhD in Epidemiology from the University of North Carolina with a focus on epidemiological methods, and completed a post-doctoral fellowship in Cancer Epidemiology at the Johns Hopkins Bloomberg School of Public Health.

    For over fifteen years her research has focused on cancer disparities in under-served settings, HIV-positive individuals, aging women. It has spanned the translational spectrum from epidemiological studies to understand the natural history of the disease, to studying the effectiveness and most recently, the implementation of cervical and breast cancer prevention methods in LMICs.

  • FOTO_VIC.jpg
    Victoria Sanchez Antelo, Ph.D.
    Researcher, Centro de Estudios de Estado y Sociedad (CEDES)

    Buenos Aires, Argentina

    Victoria Sanchez Antelo is a Sociologist with a Ph.D. in Social Science and a researcher at the Center for the Study of the State and Society (CEDES) in the Health, Economics, and Society Department. She is a member of Dr. Arrossi's team.
    Dr. Sanchez Antelo is currently a Full Professor in the Department of Health and Social Security at Universidad Nacional de Tres de Febrero and an Assistant Professor in the Faculty of Social Sciences at Universidad de Buenos Aires.
    She received a Master’s in Public Policies from Universidad Autónoma de Barcelona (Spain) and a Ph.D. in Social Science from the Buenos Aires University (Argentina) with a focus on the Sociology of health.
    She has specific training in qualitative methods applied to health research from a gender perspective. She has experience conducting qualitative research applied to the design of mHealth interventions, both to the prevention of breast and cervical cancer.
    Recently, she had training in user-experience and user-interaction research, oriented to design websites and mobile applications at National Technological University (Argentina).

  • ned-sharpless-headshot-square_0.jpg
    Norman E Sharpless, M.D.
    Director, National Cancer Institute

    Bethesda, United States

    Norman E. “Ned” Sharpless, M.D., was officially sworn in as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the director of the Lineberger (“line burger”) Comprehensive Cancer Center at the University of North Carolina (UNC).

    Dr. Sharpless was a Morehead Scholar at UNC–Chapel Hill and received his undergraduate degree in mathematics. He went on to pursue his medical degree from the UNC School of Medicine, graduating with honors and distinction in 1993. He then completed his internal medicine residency at the Massachusetts General Hospital and a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, both of Harvard Medical School in Boston. After 2 years on the faculty at Harvard Medical School, he joined the faculty of the UNC School of Medicine in the Departments of Medicine and Genetics in 2002. He became the Wellcome Professor of Cancer Research at UNC in 2012.

    Dr. Sharpless is a member of the Association of American Physicians and the American Society for Clinical Investigation, and is a Fellow of the Academy of the American Association of Cancer Research. He has authored more than 160 original scientific papers, reviews, and book chapters, and is an inventor on 10 patents. He cofounded two clinical-stage biotechnology companies: G1 Therapeutics and Sapere Bio (formerly HealthSpan Diagnostics). He served as Acting Commissioner for Food and Drugs at the US FDA for seven months in 2019, before returning to the NCI Directorship.

  • KUS_foto.JPG
    Karla Unger-Saldaña, M.D. M.Sc. Sc.D.
    Research Fellow, National Cancer Institute of Mexico

    Mexico City, Mexico

    Karla is a CONACYT (Mexican National Council of Science and Technology) research fellow working at the National Cancer Institute of Mexico in Mexico City since 2014. Currently she is doing a remote fellowship in International Health (2020-2021) at the Takemi Program, Harvard School of Public Health. Karla’s studies encompass a Medical Doctor degree, a Master’s and a Doctorate in Health Sciences. After her studies she worked for five years with a local NGO where she designed and operated programs to promote breast cancer awareness and facilitate access to screening in highly marginalized settings across Mexico. Her research has focused in understanding late diagnosis of breast cancer in Mexico, where the majority of cases are diagnosed in advanced stages. Her findings suggest that the largest proportion of delay is not due to the patients’ postponement of seeking care but to quality problems and access barriers that hinder the diagnostic and referral processes after the patient’s first contact with medical services.

  • Verna.jpg
    Verna Vanderpuye, M.D.
    Senior Consultant, National Center for Radiotherapy, Oncology and Nuclear Medicine, Korle bu Teaching Hospital

    Accra, Ghana

    Dr Vanderpuye has over 25 years experience in managing cancer and research into peculiarities of cancer in Africa. She is a senior consultant at the National Center for Radiotherapy, Oncology and Nuclear Medicine, Korle bu Teaching Hospital, Accra Ghana with affiliation to the University of Ghana, Accra. Being the female pioneer oncologist in the West African region Dr Vanderpuye has mentored many regional and international young cancer professionals throughout their training, young and middle level career phases, inculcating the Importance of a Holistic approach considering economic, socio-cultural and psychological factors, prompting research opportunities and developing cost effective, pragmatic approaches to the implementation of new evidence. She was the recipient of the 2019 International Women Who Conquer Cancer Mentorship Award from Conquer Cancer foundation. She is currently the Treasurer of African Organization for Research and Training in Cancer (AORTIC), immediate past faculty chair of her Countries postgraduate medical training program, and serves as committee member in several organizations including AORTIC , American Society of Clinical Oncology, World Health organization and the European Society of Medical Oncology. She serves on many editorial boards for highly acclaimed oncology journals and international grant review committees. Dr Vanderpuye is currently the co-chair of the new Lancet commission on women and Cancer and served as commissioner for several other Lancet commissions published and in progress. She is an international speaker and has authored/coauthored over 70 peer-reviewed journal articles, 10 book chapters and contributed to several technical documents.

  • 91-Austin Wesevich-Internal Medicine & Pediatrics_19.jpg
    Austin Wesevich, M.D., M.P.H.
    Resident, Duke University Medical Center

    Durham, United States

    Austin completed his medical and public health degrees at Washington University in St. Louis. During medical school, he researched HIV in pregnancy in Malawi through a Doris Duke International Clinical Research Fellowship from the University of North Carolina (UNC). He is wrapping up his combined Internal Medicine and Pediatrics (Med-Peds) training at Duke University this June and will then move to Chicago for an Adult Hematology/Oncology fellowship at the University of Chicago. He plans to pursue a career in adolescent/young adult (AYA) oncology and to work in sub-Saharan Africa conducting research in global oncology.

sponsor logos